Stay informed with the latest litigation news. Explore now

IP Verse

Methods Of Treating Ankylosing Spondylitis Or Psoriatic Arthritis Using Anti-Il-17 Antibodies - EP3111954B1

EP3111954

NOVARTIS
Application Number
EP16163440A
Filing Date
Nov 4, 2011
Status
Revoked
Dec 15, 2023
Grant Date
Apr 3, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP4321157B1
EP3487881B1

Bibliography

The patent EP3111954B1 was granted to Novartis on Apr 3, 2019 following the initial filing on Nov 4, 2011 under the application number EP16163440A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANTJan 3, 2020ADMISSIBLE
DR REDDYS LABORATORIESJan 2, 2020ADMISSIBLE
STRAWMANJan 2, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents